Development Pipeline
EA Pharma Co., Ltd. Development Pipeline
as of August, 2024
| herapeutic Area |
Development Code (Generic name) |
Development Stage | Indication | Note |
|---|---|---|---|---|
| Gastrointestinal diseases |
AJG555 | Phase Ⅲ | Chronic constipation in children under 2 years of age (Additional Dosage and Administration) | Oral |
| AJM347 | Phase I | Inflammatory bowel disease | Oral | |
| EA1080 | Phase I | Inflammatory bowel disease | Oral | |
| EA3571 | Phase I | Nonalcoholic steatohepatitis | Oral | |
| Neurology | EA4017 | Phase I | Chemotherapy- induced peripheral neuropathy |
Oral |
※スワイプできます
※表は左右にスクロールできます